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Comment

Using life saving commodities to save lives globally
The UN Commission on Life Saving Commodities
(UNCoLSC) was established in 2012 with an explicit aim
to secure a steady supply of key commodities across
reproductive, maternal, newborn, and child health
(RMNCH).1 Although late in the process of accelerating
progress to reach the Millennium Development Goals,
the UNCoLSC targeted securement of the supply and
uptake of 13 life saving commodities in low-income
and middle-income countries through various actions
including market shaping, regulatory eﬃciency,
innovative ﬁnancing, demand creation, and targeting
women and children at greatest risk. The evaluation
by Pronyk and colleagues2 presents a situational and
bottleneck analysis of progress in 12 of the 18 subSaharan African countries that received RMNCH trust
funds and were evaluated from 2013 to 2015.
The mixed methods approach that was used relied on
a range of participants and informants, and since the
evaluation was not independent, this could well have
overestimated progress and readiness in some countries.
These issues notwithstanding, the report details a
mixed bag of progress and lack thereof. The bottlenecks
identiﬁed are well recognised3,4 and range from an
almost universally inadequate regulatory and quality
assurance environment and supply chain, to insuﬃcient
staﬀ training and persistent stock-outs in almost
half of the facilities evaluated. Of the US$200 million
disbursed so far, almost 70% of the funds were spent on
systems strengthening ($89 million on staﬀ training,
mentorship, and support and $53 million for districtlevel monitoring and evaluation). Given the early stage
of implementation and procurements, the $21 million
spent on community mobilisation and advocacy, a
mean of $2 million per country over the last 2–3 years,
seems excessive.
This question of value for money is important,
as only a small proportion of the funds released
since 2012 have actually gone towards procuring
commodities. Although establishing a framework
for global consensus, establishing supply chains,
and understanding bottlenecks are important, the
fundamental accountability lies in ensuring that life
saving commodities reach the poorest of the poor. Many
of the issues identiﬁed with procurements, market
shaping, systems gaps, and the balance of push and
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pull factors are common to the experience of the Global
Fund around commodities for malaria, tuberculosis, and
HIV,5,6 and the training gaps are not dissimilar. I wonder
whether a more eﬃcient and rapid review process was
possible given that many of the countries targeted are
also Global Fund recipients.
Another key question is the nature of commodities
targeted by the UNCoLSC. Although a series of
technical committees provided input, the selection
of speciﬁc commodities was not standardised on
parameters of global evidence, consensus, and WHO
recommendations. For example, although the case
for deploying antenatal steroids for saving newborn
lives was built through a technical review process,7
there were no examples of successful use of antenatal
steroids among health systems in low-income and
middle-income countries. The substantial adverse
eﬀects experienced in a recent multicountry study of
antenatal steroids,8 possibly as a result of inappropriate
targeting by health workers, led to a reconsideration
of their use at scale before addressing key questions
around implementation in health systems. This work
and implementation research is led by WHO, but does
question aggressive promotion of certain commodities
in the absence of clear WHO guidelines and relevant
safety data from low-income and middle-income
countries. Similarly, ﬁndings from the 12 countries
of poor community demand and facility bottlenecks
for the use of emergency contraception and female
condoms2 also raises issues of sequencing and the
necessity of developing community demand and social
marketing around such commodities. As suggested
by Dawson and colleagues,9 the role of the private
sector in providing emergency contraception is
increasingly recognised and underscores the importance
of appropriate public–private partnerships and
performance enhancement strategies. There is therefore
a need to revisit the issue of commodity selection, and
to focus on key diagnostics and other technologies that
are clearly important for saving lives but may have been
ignored so far. Simple diagnostics can help save lives
across the continuum of care, such as pulse oximetry,10
and simple technologies are essential for triaging
babies at risk, such as low-cost weighing scales. One
of the most important commodities in short supply in
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low-income and middle-income countries is oxygen,
which can make the diﬀerence between saving the life
of a critically ill mother or young infant. A formal gap
analysis of key commodities and supply chain would
greatly help in building a list of key commodities and
delivery strategies.
What lies ahead? Clearly the extremely ambitious goals
and targets set by the UNCoLSC have not been reached,1
and challenges must be overcome. While the current
evaluation highlights several challenges and strategies
for action, a clear process in moving forward would
be to link this bottleneck analysis to the new global
strategy for Every Woman Every Child, and therefore
remain relevant to the Sustainable Development Goals.
Can this work be linked to the ﬁnancing opportunities
and country-level microplanning being undertaken by
the global ﬁnancing facility of the World Bank? How
can the work on commodities connect to the principles
of universal health care, equity, and accountability,
fundamental to the Sustainable Development Goals? It is
time to move beyond the diagnostic to focus a lot more
on implementation and achieving eﬀective coverage.
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